D-TAILS S.R.L. SB

Disruptive Technological Advances in Life Sciences
Società Benefit

D-TAILS is a deep-tech life science company focused on the development of disruptive technologies for early, non-invasive disease detection.

Our research spans neurodegenerative diseases and oncology, with a strong emphasis on biological sensing, advanced imaging, and AI-driven data analysis.

Key activities include:

Development of novel biocompatible markers for the early detection of Alzheimer’s disease, targeting Tau aggregates in the retina.

Development of non-invasive urine-based screening tests for breast, prostate, and pancreatic cancers, leveraging biological olfaction and VOC analysis.

Study of Caenorhabditis elegans as a living biosensor, investigating behavioral and neural responses to cancer-related volatile organic compounds (VOCs).

D-TAILS also develops advanced imaging platforms, including wide-field microscopy, structured illumination, adaptive optics, and integrated microfluidic solutions, designed to enable scalable, high-content biological assays.

D-Tails Research

Org chart

Teams

Offices